Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

1,131

Participants

Timeline

Start Date

March 31, 1998

Primary Completion Date

November 30, 2004

Study Completion Date

July 31, 2006

Conditions
Carcinoma, Basal CellCarcinoma, Squamous CellSkin Neoplasms
Interventions
DRUG

Tretinoin 0.1% cream or placebo

OTHER

Placebo

Patients receive placebo for same amount of time

Trial Locations (7)

27705

VA Medical Center, Durham, Durham

33125

VA Medical Center, Miami, Miami

73104

VA Medical Center, Oklahoma City, Oklahoma City

85012

Carl T. Hayden VA Medical Center, Phoenix

90822

VA Medical Center, Long Beach, Long Beach

60141-5000

Edward Hines, Jr. VA Hospital, Hines

02908

VA Medical Center, Providence, Providence

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ortho Dermatologics

INDUSTRY

lead

US Department of Veterans Affairs

FED